Equillium Inc — Cash Flow (NASDAQ:EQ) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Cash from operating activities -24.62 M-32.08 M-8.73 M-21.78 M-19.03 M -22.91 M Cash from investing activities -18.59 M27.41 M18.68 M-4.76 M13.81 M 10.49 M Cash from financing activities 53.95 M31.06 M-1.22 M-9.23 M164 K — Free cash flow -24.83 M-32.14 M-9.01 M-21.83 M-19.11 M -22.92 M

ニュース

Stifel首次覆盖Equillium股票基于IBD潜力给予买入评级

Stifel initiates Equillium stock with buy rating on IBD potential

Equillium principal accounting officer Tom Penny sells $8427 in stock

Equillium SVP Zedelmayer sells $7.7k in stock

The Zacks Analyst Blog Highlights MS, VOO, SPY, IVV, SPYM, RSP, EQ and EQWL

Equillium, Inc. (EQ) Discusses Aryl Hydrocarbon Receptor as a Drug Target and EQ504 Program in Immune-Mediated Diseases - Slideshow (NASDAQ:EQ) 2025-11-09

Equillium announces leadership changes as it shifts focus to EQ504

Equillium提交招股说明书补充文件，拟发行最高7500万美元股票

Equillium files prospectus supplement for up to $75 million stock offering

These Were the 5 Top-Performing Stocks in the Nasdaq Composite in August 2025

Equillium: Pushing Forward With AhR Activation Drug Candidate EQ504 For UC (NASDAQ:EQ)

Equillium Stock (EQ) Rockets 140% on $50M Private Placement - TipRanks.com